Jane Street
ENTX icon

Jane Street’s Entera Bio ENTX Stock Holding History

Jane Street’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7K Sell
17,331
-15,584
-47% -$19.5K ﹤0.01% 11093
2026
Q1 		$36.5K Sell
32,915
-41,149
-56% -$57.7K ﹤0.01% 11070
2025
Q4 		$144K Buy
74,064
+43,536
+143% +$102K ﹤0.01% 9966
2025
Q3 		$58.6K Buy
30,528
+20,341
+200% +$38.9K ﹤0.01% 10304
2025
Q2 		$19.4K Buy
+10,187
New +$20.1K ﹤0.01% 9363
2021
Q4 		– Sell
-11,563
Closed -$54K – 10238
2021
Q3 		$54K Buy
+11,563
New +$59.3K ﹤0.01% 9526

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Jane Street's ENTX Position: Q2 2026 in Review

Jane Street reduced its Entera Bio (ENTX) stake by 47% in Q2 2026, selling an estimated $19.5K and leaving 17,331 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11093.

Jane Street first reported a position in ENTX in Q3 2021 and has held it in 6 quarters since. The position peaked at $144K in Q4 2025. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Jane Street held 17,331 shares of Entera Bio worth $30.7K as of Q2 2026.
  • Jane Street sold 15,584 Entera Bio shares in Q2 2026, an estimated $19.5K.
  • Entera Bio made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11093 holding.
  • Jane Street first reported a position in Entera Bio in Q3 2021 and has held it in 6 quarters since.
  • Jane Street's Entera Bio position peaked at $144K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.